Ziva Abraham

CEO and Principal Consultant

Microrite, USA

 

Ziva Abraham is the President and Founder of Microrite Inc., a California-based GMP consulting firm specializing in contamination control. With over 35 years of academic research, clinical, and industrial experience in microbiology and quality assurance, Ziva is a recognized expert in her field. She holds a Master’s degree in Microbiology and has conducted extensive research on developing microbial insecticides using entomogenous bacteria and fungi towards her Ph.D.

 

Ziva’s professional journey began in clinical microbiology, where she established laboratory systems and evaluated the first automated microbial identification systems. She introduced new technologies for HIV testing and other rapid methods into the clinical laboratories she managed in Israel. These laboratories conducted comprehensive testing in microbiology, chemistry, parasitology, hematology, and immunology.

 

In 1998, Ziva founded Microrite Inc., leveraging her extensive experience to build a team of experts in contamination control. Her team includes professionals in facilities, cleanroom airflow, static charge validation, quality, and microbiology. Microrite is renowned for resolving client issues, preventing contamination through design, and ensuring the production of safe products for human and veterinary use.

 

Ziva is a passionate educator and provides training worldwide on various topics related to microbiology and contamination control. Her clinical background enables her to evaluate and teach the clinical implications of microbial contamination on patients. She is also actively involved in industry standards and guidance organizations, contributing to the development of contamination control standards and best practices.

 

Ziva’s contributions to the field are recognized through numerous awards and accolades. She continues to be an influential figure in microbiology and contamination control, sharing her knowledge through seminars, publications, and training sessions globally.